Suggestions
Jonathan Sackner-Bernstein
Drug and Device Development Expert; ex-FDA; ex-DARPA
Jonathan Sackner-Bernstein, MD is a highly accomplished physician, innovator, and medical executive with a diverse background spanning academia, government agencies, and private sector roles.135 He is currently focused on transforming Parkinson's disease treatment, having discovered and developed a groundbreaking therapy that challenges established standards of care.5
Key aspects of Dr. Sackner-Bernstein's career include:
-
Education: He holds a BS in Electrical Engineering from the University of Pennsylvania and an MD from Jefferson Medical College.4
-
Academic and Research Experience: He has published around 80 scientific articles cited over 4,000 times, with notable research on cardiac care and drug efficacy.4 His work led to increased scrutiny of the drug Nesiritide.4
-
Government Service: Dr. Sackner-Bernstein served as Associate Center Director at the FDA's Center for Devices and Radiological Health, where he led post-market operations and innovation programs.45 He also worked with DARPA, focusing on neuroscience and big data programs.15
-
Industry Roles: He has held positions such as Chief Medical Officer and Executive VP of Clinical and Regulatory Affairs at companies like ROX Medical.2 His expertise spans medical devices, pharmaceuticals, and cell therapies.1
-
Current Focus: Dr. Sackner-Bernstein is developing a novel approach to treating Parkinson's disease, which challenges current treatment paradigms.5
-
Recognition: He was named to the "Worthy 100" list in 2023, acknowledging his contributions to the field.3
Dr. Sackner-Bernstein's unique combination of engineering background, medical expertise, and experience with regulatory agencies has positioned him as a respected innovator in the medical field.15
